Cytogenetic complexity and heterogeneity in intravascular lymphoma.


Journal

Journal of clinical pathology
ISSN: 1472-4146
Titre abrégé: J Clin Pathol
Pays: England
ID NLM: 0376601

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 14 03 2020
revised: 26 05 2020
accepted: 09 06 2020
pubmed: 9 8 2020
medline: 30 3 2021
entrez: 9 8 2020
Statut: ppublish

Résumé

To characterise the karyotypic abnormalities and heterogeneities in intravascular lymphoma (IVL). G-banded karyotyping was performed on biopsy specimens from a single-centre IVL cohort comprising intravascular large B-cell lymphoma (IVLBCL, n=12) and NK/T-cell lymphoma (IVNKTCL, n=1). Five IVLBCL cases and one IVNKTCL case (total 46%) were found to have normal karyotypes, and the cytogenetic abnormalities observed in the other seven IVLBCL cases (54%) were investigated further. These seven karyotypes were uniformly complex with an average of 13 aberrations. The seven cases all had abnormalities involving chromosome 6, with 57% involving structural abnormalities at 6q13, and chromosome 8, with 43% involving abnormalities at 8p11.2. In addition, 71% had aberrations at 19q13. On average, 4.4 chromosomal gains and losses were detected per case. Cytogenetic heterogeneities were observed in six cases (86%) and tetraploidy in three cases (43%). There was no significant difference in progression-free survival (p=0.92) and overall survival (p=0.61) between the IVLBCL cases with complex and normal karyotypes. Approximately half of IVLBCL cases had a highly heterogeneous pattern of karyotypes with different clonal numerical and structural chromosome aberrations.

Identifiants

pubmed: 32763919
pii: jclinpath-2020-206573
doi: 10.1136/jclinpath-2020-206573
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

244-250

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kohei Fujikura (K)

Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan kfuji@med.kobe-u.ac.jp.
Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.

Daisuke Yamashita (D)

Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.

Makoto Yoshida (M)

Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.

Takayuki Ishikawa (T)

Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

Tomoo Itoh (T)

Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.

Yukihiro Imai (Y)

Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH